StephenDNimerMD

PubMed

• Genome-wide screening identifies Trim33 as an essential regulator of dendritic cell differentiation.
  Ioanna Tiniakou, Pei-Feng Hsu, Lorena S Lopez-Zepeda, Görkem Garipler, Eduardo Esteva, Nicholas M Adams, Geunhyo Jang, Chetna Soni, Colleen M Lau, Fan Liu, Alireza Kho...> ;Science Immunology. 2024 Apr 12
• Targeting lysine demethylase 6B ameliorates ASXL1 truncation-mediated myeloid malignancies in preclinical models.
  Ge, G., Zhang, P., Sui, P., Chen, S., Yang, H., Guo, Y., Rubalcava, I., Noor, A., Delma, C., Agosto-Peña, J., Geng, H., Medina, E., Liang, Y., Nimer, S., Mesa, R., Abd...> ;The Journal of Clinical Investigation. 2024 Jan 2
• 4 citations
  Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Cons...
  Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami Komrokji, Mina L Xu, Omar Abdel-Wahab, Justin Taylor, David P Steensma, Daniel ...> ;Blood Reviews. 2023 Nov 1
• 1 citations
  Loss of BRD4 induces cell senescence in HSC/HPCs by deregulating histone H3 clipping.
  Hui Yang, Pinpin Sui, Ying Guo, Shi Chen, Marie E Maloof, Guo Ge, Francine Nihozeko, Caroline R Delma, Ganqian Zhu, Peng Zhang, Zhenqing Ye, Edward A Medina, Nagi G Ay...> ;EMBO Reports. 2023 Oct 9
• 1 citations
  The SWI/SNF chromatin-remodeling subunit DPF2 facilitates NRF2-dependent antiinflammatory and antioxidant gene expression.
  Gloria Mas, Na Man, Yuichiro Nakata, Concepcion Martinez-Caja, Daniel Karl, Felipe Beckedorff, Francesco Tamiro, Chuan Chen, Stephanie Duffort, Hidehiro Itonaga, Adnan...> ;The Journal of Clinical Investigation. 2023 Jul 3
• 4 citations
  Combined Use of RT-qPCR and NGS for Identification and Surveillance of SARS-CoV-2 Variants of Concern in Residual Clinical Laboratory Samples in Miami-Dade County, Flo...
  Yamina L Carattini, Anthony Griswold, Sion Williams, Ranjini Valiathan, Yi Zhou, Bhavarth Shukla, Lilian M Abbo, Katiuska Parra, Merce Jorda, Stephen D Nimer, Corneliu...> ;Viruses. 2023 Feb 21
• 3 citations
  Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia.
  John P Brabson, Tiffany Leesang, Yoon Sing Yap, Jingjing Wang, Minh Q Lam, Byron Fang, Igor Dolgalev, Daniela A Barbieri, Victoria Strippoli, Carolina P Bañuelos, Sofi...> ;Cell Reports. 2023 Jan 31
• 8 citations
  Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures.
  Benjamin Diamond, Bachisio Ziccheddu, Kylee Maclachlan, Justin Taylor, Eileen Boyle, Juan Arango Ossa, Jacob Jahn, Maurizio Affer, Tulasigeri M Totiger, David Coffey, ...> ;Blood. 2023 May 11
• 13 citations
  Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes.
  Amer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A Sekeres, David P Steensma, Uwe Platzbecker, Sanam Loghavi, Jacqueline Boultwood, Rafael Bejar, John M ...> ;Leukemia. 2022 Dec 1
• 4 citations
  An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.
  Maximilian Stahl, Omar Abdel-Wahab, Andrew H Wei, Michael R Savona, Mina L Xu, Zhuoer Xie, Justin Taylor, Daniel Starczynowski, Guillermo F Sanz, David A Sallman, Vale...> ;Blood Advances. 2023 Jun 27
• 4 citations
  Epigenetic and Transcriptional Regulation of Innate Immunity in Cancer.
  Chuan Chen, Na Man, Fan Liu, Gloria Mas Martin, Hidehiro Itonaga, Jun Sun, Stephen D Nimer> ;Cancer Research. 2022 Jun 6
• Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learning.
  David A Sallman, Rafael Bejar, Guillermo Montalban-Bravo, Sandra E Kurtin, Alan F List, Guillermo Garcia-Manero, Stephen D Nimer, Casey L O'Connell, Dale Schaar, Janic...> ;Leukemia Research Reports. 2022 Jan 1
• 10 citations
  p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia
  Na Man, Gloria Mas, Daniel L. Karl, Jun Sun, Fan Liu, Qin Yang, Miguel Torres-Martin, Hidehiro Itonaga, Concepción Martínez, Shi Chen, Ye Xu, Stephanie Duffort, Pierre...> ;JCI Insight. 2021 Oct 8
• 5 citations
  INTS11 regulates hematopoiesis by promoting PRC2 function.
  Peng Zhang, Pinpin Sui, Shi Chen, Ying Guo, Ying Li, Guo Ge, Ganqian Zhu, Hui Yang, Cody M. Rogers, Patrick Sung, Stephen D. Nimer, Mingjiang Xu, Feng Chun Yang> ;Science Advances. 2021 Sep 3
• 8 citations
  RAC1 plays an essential role in estrogen receptor alpha function in breast cancer cells.
  Jun Sun, Gabriel Gaidosh, Ye Xu, Adnan K. Mookhtiar, Na Man, Pradeep Reddy Cingaram, Ezra Blumenthal, Ramin Shiekhattar, Erik T. Goka, Stephen D. Nimer, Marc E. Lippman> ;Oncogene. 2021 Aug 9
• 11 citations
  Methylation of dual-specificity phosphatase 4 controls cell differentiation.
  Hairui Su, Ming Jiang, Chamara Senevirathne, Srinivas Aluri, Tuo Zhang, Han Guo, Juliana Xavier-Ferrucio, Shuiling Jin, Ngoc Tung Tran, Szu Mam Liu, Chiao-Wang Sun, Yo...> ;Cell Reports. 2021 Jul 27
• 25 citations
  HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia
  Ganqian Zhu, Huacheng Luo, Yang Feng, Olga A. Guryanova, Jianfeng Xu, Shi Chen, Qian Lai, Arati Sharma, Bing Xu, Zhigang Zhao, Ru Feng, Hongyu Ni, David F. Claxton, Yi...> ;Nature Communications. 2021 Mar 29
• 3 citations
  A How-to Guide to Building a Robust SARS-CoV-2 Testing Program at a University-Based Health System
  Stephen D. Nimer, Jennifer R. Chapman, Lisa Reidy, Alvaro J. Alencar, Yan Yun Wu, Sion L. Williams, Lazara Pagan, Lauren N. Gjolaj, Jessica MacIntyre, Melissa Triana, ...> ;Academic Pathology. 2020 Sep 30
• 26 citations
  Acute Myeloid Leukemia iPSCs Reveal a Role for RUNX1 in the Maintenance of Human Leukemia Stem Cells
  Josephine Wesely, Andriana G. Kotini, Franco Izzo, Hanzhi Luo, Han Yuan, Jun Sun, Maria Georgomanoli, Asaf Zviran, André G. Deslauriers, Neville Dusaj, Stephen D. Nime...> ;Cell Reports. 2020 Jun 2
• 30 citations
  PRMT5-mediated histone arginine methylation antagonizes transcriptional repression by polycomb complex PRC2.
  Fan Liu, Ye Xu, Xiaoqing Lu, Pierre-Jacques Hamard, Daniel L. Karl, Na Man, Adnan K. Mookhtiar, Concepción Martínez, Izidore S. Lossos, Jun Sun, Stephen D. Nimer> ;Nucleic Acids Research. 2020 Apr 6
• 21 citations
  Targeted chemotherapy overcomes drug resistance in melanoma
  Jingyin Yue, Roberto Vendramin, Fan Liu, Omar Lopez, Monica Guiselle Valencia, Helena G. Dos Santos, Gabriel Gaidosh, Felipe Beckedorff, Ezra Blumenthal, Lucia Speroni...> ;Genes & Development. 2020 May 1
• 29 citations
  SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS
  Bing Yi Chen, Junhong Song, Cheng Long Hu, Shu Bei Chen, Qun-Ling Zhang, Chun Hui Xu, Ji Chuan Wu, Dan Hou, Ming Sun, Yuan Liang Zhang, Na Liu, Peng Cheng Yu, Ping Liu...> ;Blood. 2020 Jun 18
• 26 citations
  TAF1 plays a critical role in AML1-ETO driven leukemogenesis.
  Ye Xu, Na Man, Daniel L. Karl, Concepción Martínez, Fan Liu, Jun Sun, Camilo Martinez, Gloria Mas Martin, Felipe Beckedorff, Fan Lai, Jingyin Yue, Alejandro Roisman, S...> ;Nature Communications. 2019 Oct 29
• 5 citations
  Risk of disease progression in low-risk MDS is linked to distinct epigenetic subtypes
  Tingting Qin, Jason Sotzen, Raajit K. Rampal, Franck Rapaport, Ross L. Levine, Virginia M. Klimek, Stephen D. Nimer, Maria E. Figueroa> ;Leukemia. 2019 Jul 22
• 5 citations
  Destabilization of AETFC through C/EBPα-mediated repression of LYL1 contributes to t(8;21) leukemic cell differentiation.
  Meng Meng Zhang, Na Liu, Yuan Liang Zhang, Bowen Rong, Xiao Lin Wang, Chun Hui Xu, Yin Yin Xie, Shuhong Shen, Jiang Zhu, Stephen D. Nimer, Zhu Chen, Sai Juan Chen, Rob...> ;Leukemia. 2019 Feb 12
• Join now to see all

Journal Articles

• Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia  
  Shih AH, Jiang Y, Meydan C, Shank K, Pandey S, Barreyro L, Antony-Debre I, Viale A, Socci N, Sun Y, Robertson A, Cavatore M, de Stanchina E, Hricik T, Rapaport F, Wood..., Cancer Cell, 1/13/2015
• PARP inhibitors: a treatment option for AML?  
  Wang L, Hamard PJ, Nimer SD, Nature Medicine, 1/1/2015
• The Role of Histone Acetyltransferases in Normal and Malignant Hematopoiesis  
  Sun XJ, Man N, Tan Y, Nimer SD, Wang L, Front Oncol, 1/1/2015
• Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS  
  List AF, Bennett JM, Sekeres MA, Skikne B, Fu T, Shammo JM, Nimer SD, Knight RD, Giagounidis A, Leukemia, 1/1/2015
• A Hyperactive Signalosome in Acute Myeloid Leukemia Drives Addiction to a Tumor-Specific Hsp90 Species  
  Zong H, Gozman A, Caldas-Lopes E, Taldone T, Sturgill E, Brennan S, Ochiana SO, Gomes-DaGama EM, Sen S, Rodina A, Koren J 3rd, Becker MW, Rudin CM, Melnick A, Levine R..., Cell Reports, 1/1/2015
• Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice  
  Zhao Z, Chen L, Dawlaty MM, Pan F, Weeks O, Zhou Y, Cao Z, Shi H, Wang J, Lin L, Chen S, Yuan W, Qin Z, Ni H, Nimer SD, Yang FC, Jaenisch R, Jin P, Xu M, Cell Reports, 1/1/2015
• PRMT5 is essential for sustaining adult hematopoietic stem and progenitor cells  
  Liu F, Cheng G, Hamard PJ, Greenblatt S, Wang L, Man N, Perna F, Xu H, Tadi M, Luciani L, Nimer SD, Journal of Clinical Investigation, 1/1/2015
• Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression  
  Wang L, Man N, Sun XJ, Tan Y, Cao M, Liu F, Hatlen M, Xu H, Huang G, Mattlin M, Mehta A, Rampersaud E, Benezra R and Nimer S, Blood, 1/1/2015
• Loss of RUNX1/AML1 arginine-methylation impairs peripheral T cell homeostasis  
  Mizutani S, Yoshida T, Zhao X, Nimer SD, Taniwaki M, Okuda T., Br J Haematol, 1/1/2015
• The Polycomb group protein L3MBTL1 represses a SMAD5-mediated transcriptional program in human pluripotent stem cells  
  Perna F, Vu L, Themeli M, Kriks S, Hoya-Arias R, Khanin R, Hricik T, Mansilla-Soto J, Papapetrou EP, Levine R, Studer L, Sadelain M, Nimer SD, Stem Cell Reports, 1/1/2015
• Functional dissection of hemizygous chromosomal deletions with human induced pluripotent stem cell models of myelodysplastic syndromes  
  Kotini AG, Chang C, Boussaad I, Delrow JJ, Dolezal EK, Nagulapally A, Perna F, Fishbein GA, Klimek VM, Hawkins DR, Huangfu D, Murry CE, Graubert T, Nimer SD, Papapetro..., Nature Biotechnology, 1/1/2015
• DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia  
  Rampal R, Alkalin A, Madzo J, Vasanthakumar A, Pronier E, Patel J, Li Y, Ahn J, Abdel-Wahab O, Shih A, Lu C, Ward PS, Tsai JJ, Hricik T, Tosello V, Tallman JE, Zhao X,..., Cell Rep., 1/1/2014
• Down-regulation of RUNX1/CBFß by MLL fusion proteins enhances HSC self-renewal  
  Zhao X, Chen A, Yan X, Zhang Y, He F, Hayashi Y, Dong Y, Rao Y, Li B, Conway RM, Maiques-Diaz A, Elf SE, Huang N, Zuber J, Xiao Z, Tse W, Tenen DG, Wang Q, Chen W Jull..., Blood, 1/1/2014
• Histone-modifying enzymes: their roles in the pathogenesis of acute leukemia and their therapeutic potential  
  Vu LP, Luciani L, Nimer SD, Int J Hematol, 1/1/2013
• PRMT4 Blocks Myeloid Differentiation by Assembling a Methyl-RUNX1-Dependent Repressor Complex  
  Vu LP, Perna F, Wang L, Voza F, Figueroa ME, Tempst P, Erdjument-Bromage H, Gao R, Chen S, Paietta E, Deblasio T, Melnick A, Liu Y, Zhao X, Nimer SD, Cell Reports, 1/1/2013
• Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death  
  Altman JK, Rademaker A, Cull E, Weitner B, Ofran Y, Rosenblat T, Haidau A, Park J, Ram S, Orsini Jr. J, Sandhu S, Catchatourian R, Trifilio S, Adel N, Frankfurt O, Ste..., Leuk Res, 1/1/2013
• Mutations in the nucleolar phosphoprotein, nucleophosmin, promote the expression of the oncogenic transcription factor MEF/ELF4 in leukemia cells and potentiates trans...  
  Ando K, Tsushima H, Matsuo E, Horio K, Tominaga-Sato S, Imanishi D, Imaizumi Y, Iwanaga M, Itonaga H, Yoshida S, Hata T, Moriuchi R, Kiyoi H, Nimer S, Mano H, Naoe T, ..., J Biol Chem, 1/1/2013
• MEF promotes stemness in the pathogenesis of gliomas  
  Bazzoli E, Pulvirenti T, Oberstadt MC, Perna F, Wee B, Schultz N, Huse JT, Fomchenko EI, Voza F, Tabar V, Brennan CW, DeAngelis LM, Nimer SD, Holland EC, Squatrito M, Cell Stem Cell, 1/1/2012
• An Inv(16)(p133q243)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia  
  Gruber TA, Larson Gedman A, Zhang J, Koss CS, Marada S, Ta HQ, Chen SC, Su X, Ogden SK, Dang J, Wu G, Gupta V, Andersson AK, Pounds S, Shi L, Easton J, Barbato MI, Mul..., Cancer Cell, 1/1/2012
• Loss of p53 accelerates the complication of myelodysplastic syndrome (MDS) in a NUP98-HOXD13 driven mouse model  
  Xu H, Menendez S, Schlegelberger B, Bae N, Aplan PD, Gohring G, Deblasio TR, Nimer SD, Blood, 1/1/2012
• ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene expression  
  Abdel-Wahab O, Adli M, LaFave LM, Gao J, Hricik T, Shih AH, Pandey S, Patel JP, Chung YR, Koche R, Perna F, Zhao X, Taylor JE, Park CY, Carroll M, Melnick A, Nimer SD,..., Cancer Cell, 1/1/2012
• The Checkpoint Kinase Inhibitor AZD7762 Potentiates Chemotherapy Induces Apoptosis of p53 Mutated Multiple Myeloma Cells  
  Landau HJ, McNeely SC, Nair JS, Comenzo RL, Asai T, Friedman H, Jhanwar SC, Nimer SD, Schwartz GK, Mol Cancer Ther, 1/1/2012
• PRMT1 interacts with AML1- ETO to promote its transcriptional activation and progenitor cell proliferative potential  
  Shia WJ, Okumura AJ, Yan M, Sarkeshik A, Lo MC, Matsuura S, Komeno Y, Zhao X, Nimer SD, Yates JR 3rd, Zhang DE, Blood, 1/1/2012
• Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma  
  Moskowitz CH, Matasar MJ, Zelenetz AD, Nimer SD, GerecitanoJ, Hamlin P, Horowitz S, Moskowitz AJ, Noy A, Palomba L, Perales MA, Portlock C, Straus D, Maragulia JC, Sch..., Blood, 1/1/2012
• Myelodysplastic syndromes  
  Greenberg PL, Attar E, Bennett JM, Bloomfield CD, De Castro CM, Deeg HJ, Foran JM, Gaensler K, Garcia-Manero G, Gore SD, Head D, Komrokji R, Maness LJ, Millenson M, Ni..., P.J Natl Compr Canc Netw, 1/1/2011
• Join now to see all

Books/Book Chapters

• Myelodysplastic Syndromes 
  Chapter: MDS Stem Cell Biology. 
  Page 73 - 84Greenblatt SM, H. Joachim Deeg, Nimer SDSpringerEdition 2nd,2013
• Cancer Rehabilitation: Principles and Practice 
  Chapter: Evaluation and Treatment of Leukemia and Myelodysplasia. 
  Page 253 - 266Landau H & Nimer SDEditors: Michael D. Stubblefield and Michael W. O'Dell.2009
• Myelodysplastic Syndromes: State of the Art 
  Chapter: Molecular and Genetic Abnormalities in MDS. 
  Page 37 - 56Nimer SDE-Hellstrom-Lindberg2008
• Clinical Malignant Hematology 
  Chapter: Treatment Approach to Early Myelodysplastic Syndromes. 
  Klimek V, Nimer SEditors: Sekeres MA, Kalaycio ME, Bolwell BJ.McGraw - Hill, New York2007
• Transcription Factors: Normal and Malignant Development of Blood Cells 
  Chapter: t(8;21) AML and the AML1/ETO fusion gene: From clinical syndrome to paradigm for the molecular basis of acute leukemia. 
  Page 409 - 424Frank RC, Nimer SDEditors: Ravid K, Licht J.John Wiley & Sons2001
• Developmental Biology of Hematopoiesis 
  Chapter: Transcription Factors Active in Megakaryocyte Development. 
  Page 443 - 449Nimer SDEditors: Zon LI.Oxford University Press2001
• Current Controversies in Bone Marrow/Stem Cell Transplantation 
  Chapter: Autologous Transplantation for Hodgkin's Disease: Who Benefits? 
  Page 137 - 145Moskowitz CH, Nimer SDEditors: Bolwell BJ.Humana Press2000
• Molecular Biology in Cancer Medicine 
  Chapter: Transcription Factors and Malignancy. 
  Page 147 - 159Frank RC, Nimer SDEditors: Kurzrock R, Talpaz M.Martin Dunitz Publ., LondonEdition 2nd,1999
• Molecular Biology of Hematopoiesis 
  Chapter: IL3BP1, a transcription factor with dual function. 
  Page 397 - 402Zhang W, Look AT, Inaba T, Nimer SDEditors: Abraham NG.Plenum Press, NY1996
• Conn's Current Therapy 
  Chapter: Aplastic Anemia. 
  Page 333 - 336Nimer, SD, Childs BHEditors: Rakel R.W.B. Saunders Co.1996
• USMLE Step 1 Review: The Study Guide 
  Chapter: Hematopoietic and Lymphoreticular Systems. 
  Page 295 - 308Nimer SD, Pavlick ACEditors: Goldberg, JS.Sage Publications, Thousand Oaks, CA1996
• Ontogeny of Hematopoiesis. Aplastic Anemia 
  Chapter: The role of cytokines in the pathogenesis and treatment of aplastic anemia and myelodysplastic syndromes. 
  Page 353 - 359Nimer SDEditors: Gluckman E, Coulombel L.John Libbey Eurotext Ltd, Paris1995
• The Year Book of Oncology 
  Chapter: Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. 
  Page 474 - 476Nimer SD, Giorgi J, Gajewski JL, Ku N, Schiller GJ, Lee K, Territo M, Ho, W, Feig S, Selch M, Isacescu V, Reichert TA, Champlin REEditors: Simone, JV.Mosby, Inc., St. Louis, MO1995
• Molecular Biology in Clinical Oncology and Hematology 
  Chapter: Transcription Factors and Malignancy. 
  Page 113 - 128Nimer SDEditors: Kurzrock R, Talpaz M.Martin Dunitz Publ., London1995
• Blood: Principles and Practice of Hematology 
  Chapter: Molecular, cell and clinical biology of the phagocyte. 
  Page 513 - 541Nimer SD, Golde DWEditors: Handin RI, Lux SE, Stossel TP.J.B. Lippincott Co1995
• The Instant Exam Review for the USMLE Step 3 
  Chapter: "Hematology and Oncology" 
  Page 97 - 114Nimer SD, Pavlick AEditors: Goldberg, JS.Appleton and Lange, Norwalk, CT1994
• Pathology of the Bone Marrow 
  Chapter: Bone marrow structure and function. 
  Page 1 - 31Naeim F, Nimer SIgaku Shoin, NY1992
• Manual of Clinical Laboratory Immunology 
  Chapter: Hematopoietic growth factors. 
  Page 244 - 247Nimer SDEditors: Rose NR, de Macario EC, Fahey JL, Friedman H, Renn GM.American Society for Microbiology, Washington, DCEdition 4th,1992
• Bone Marrow Transplantation 
  Chapter: . Therapeutic use of hematopoietic growth factors in bone marrow transplantation. 
  Page 141 - 164Nimer SD, Champlin REEditors: Champlin RE.Kluwer Academic Publishers, Norwell, MA1990
• Proceedings of the American Red Cross Annual Symposium on Hematopoietic Growth Factors in Transfusion Medicine 
  Chapter: Human granulocyte-macrophage colony-stimulating factor (GM-CSF): regulation of expression. 
  Page 27 - 41Gasson JC, Fraser JK, Nimer SDEditors: Spivak J, Drohan W, Dooley D.Alan R. Liss, NY1990
• Early Human Retroviruses. UCLA Symposia on Molecular and Cellular Biology 
  Chapter: The effects of tax and rex protein of HTLV-I and -II on viral and cellular gene regulation. 
  Page 33 - 47Black AC, Nimer SD, Chen ISY, Rosenblatt JDEditors: Groopman J, Chen ISY, Essex M, Weiss R.Alan R. Liss, NY1990
• The Year in Immunology, 1986-87 
  Chapter: Expression and target cell specificity of human granulocyte-macrophage colony-stimulating factor. 
  Page 6084 - 6088Nimer SD, Gasson JC, DiPersio JFEditors: Cruse JM, Lewis RE.Karger, Basel, Switzerland1988
• Recent Advances in Leukemia and Lymphoma, UCLA Symposia on Molecular and Cellular Biology 
  Chapter: Identification of regulatory sequences in the 5' flanking region of the human GM-CSF gene. 
  Page 229 - 238Nimer SD, Gasson JCEditors: Gale RP, Golde DW.Alan R. Liss, Inc., NY1987
• Platelets: Recent Advances in Basic Research and Clinical Aspects 
  Chapter: The effect of certain alkyl-substituted analogues of nitrofurantoin upon platelet aggregation. 
  Page 324 - 328Rossi EC, Nimer S, Louis GEditors: Ulutin ON.Excerpta Medica/American Elsevier, Amsterdam1975
• Join now to see all

Abstracts/Posters

• EP300 Suppresses Leukemia Development in Myelodysplastic Syndrome through Myb Repression
  Stephen Nimer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Precision Hematology in Myelodysplastic Syndromes 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• "What are the treatment options?" 
  Sylvester Comprehensice Cancer Center, Miami, FL - 1/28/2015
• "Myelodysplastic Syndromes" 
  Cartagena, Colombia - 1/22/2015
• "Targeting histone modifying enzymes in the treatment of acute leukemia" 
  Miami, FL - 1/19/2015
• "Using targeted therapy to overcome the heterogeneity of acute leukemia" 
  HI - 1/17/2015
• "Key Updates for 2015" 
  Miami - 1/7/2015
• "Program Overview and Objectives" 
  Orlando, FL - 1/4/2015
• "Epigenetic Focused Therapies for Acute Leukemia" 
  Tampa - 1/2/2015
• "Histone Modifying Enzymes" 
  Boston, MA - 1/28/2014
• "Role of arginine methyltransferases in hematological malignancies" 
  Miami, FL - 1/14/2014
• "The role of arginine methyltransferases in normal and malignant hematopoiesis" 
  Cincinnati Children's Hospital Medical Center, Cincinnati, OH - 1/6/2014
• "Therapeutic and prognostic role of epigenetic abnormalities in MDS" 
  San-Francisco, CA - 1/4/2014
• "Gene Expression in MDS and AML" 
  New York, NY - 1/20/2013
• "Epigenetics and Stem Cells" 
  Asheville, NC - 1/18/2013
• "Role of protein arginine methylation in regulating cancer" 
  Il Ciocco, Barga (Lucca), Italy - 1/18/2013
• "The Role of Arginine Methyltransferases in Hematologic Malignancies" 
  Florence, Italy - 1/14/2013
• "Contemporary Stem Cell Transplants and Current Research" 
  Rome, Italy - 1/10/2013
• "Targeting Histone Modifying Enzymes to Treat Hematologic Malignancies" 
  McArdle Laboratory for Cancer Research, University of Wisconsin-Madison - 1/9/2013
• "Treatment of High Risk MDS Patients" 
  Berlin, Germany - 1/7/2013
• "PRMT5 and normal/malignant hematopoiesis" 
  Saxton River, VT - 1/4/2013
• "Oncogenic transcription factors and leukemogenesis" 
  Gainesville, FL - 1/4/2013
• "Stem Cell Science-Cancer" 
  West Palm Beach, FL - 1/6/2012
• "Leukemogenic Properties of Histone Modifying Enzymes" 
  University of Toronto, MaRS Center Auditorium, Toronto, ON, Canada - 1/1/2012
• "Targeting Epigenetic Modifiers in AML" 
  Philadelphia, PA - 1/1/2012
• "NCCN Guidelines" 
  Madrid, Spain - 1/1/2012
• Join now to see all

Other

• MDS: A Stem Cell Disorder- But What Exactly is Wrong with the Primitive Hematopoietic Cells in This Disease? 
  Nimer SD, Hematology Am Soc Hematol Educ Program
  1/1/2008